News & Analysis as of

Drug Safety Analytics

Foley & Lardner LLP

FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness

Foley & Lardner LLP on

The U.S. Food and Drug Administration (FDA) has recently issued guidance for sponsors and investigators interested in submitting a non-interventional study, commonly known as an observational study, to contribute evidence of...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide